Study Suggests Symbiotic May Help Prevent Long Covid


 A new study from Hong Kong has investigated the effects of a novel treatment for patients who suffer from long-term symptoms after recovering from Covid-19. The treatment, called SIM01, is a symbiotic preparation that contains beneficial bacteria and yeast that may help restore the balance of the gut microbiome and improve immune function. The study, led by Raphaela I Lau and colleagues, was a randomized, double-blind, placebo-controlled trial that enrolled 120 patients with post-acute Covid-19 syndrome (PACS), also known as long Covid. PACS is a condition that affects many people who have survived Covid-19, causing persistent symptoms such as fatigue, shortness of breath, brain fog, anxiety and depression. The researchers hypothesized that SIM01 (b.adolescentis, b. longum) could reduce inflammation and oxidative stress, enhance mucosal barrier integrity and modulate the gut-brain axis, thereby alleviating PACS symptoms. The participants were randomly assigned to receive either SIM01 or a placebo for 12 weeks, and their symptoms, quality of life, gut microbiota composition and inflammatory markers were assessed at baseline and at the end of the trial. The results showed that SIM01 was well tolerated and safe, and significantly improved the physical and mental health of the PACS patients compared to the placebo group. The SIM01 group also had lower levels of inflammatory cytokines and higher levels of beneficial bacteria in their gut microbiota. The researchers concluded that SIM01 is a promising therapeutic option for PACS patients and suggested that further studies are needed to confirm its efficacy and mechanism of action.

Talk to your doctor about the results of this study if you have Covid-19. Several symbiotics are available on Amazon that have these probiotics/prebiotics.

Comments